Latest Headlines
-
QIAGEN Reaches Milestone With Over 1,000 Placements Of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation
12/5/2024
QIAGEN today announced it has reached a significant milestone with over 1,000 placements of the EZ2 Connect automated sample preparation instrument, an advancement of the EZ1 instrument line.
-
Indica Labs Joins The AWS Partner Network
12/4/2024
Indica Labs, the global leader in AI-powered digital pathology software and services, announced today that they have joined the Amazon Web Services (AWS) Partner Network (APN).
-
Nikon And eLabNext Collaborate To Integrate The NIS-Elements Imaging Platform With eLabNext's Digital Lab Platform In The US
12/4/2024
Nikon and eLabNext partner to enhance data integration between NIS-Elements imaging software and eLabNext’s Digital Lab Platform.
-
Solid Biosciences Announces Collaboration With Mayo Clinic To Accelerate Gene Therapy Innovation And Advance Development Of Cardiac Gene Therapies
12/4/2024
Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a collaboration with Mayo Clinic seeking to advance a cutting-edge AAV gene therapy platform for the development of next-generation therapies to treat sudden cardiac death-predisposing genetic cardiomyopathies and channelopathies with high unmet medical need and significant patient populations.
-
ESYA Labs Partners With Alamar Biosciences To Advance Biomarker Detection And Diagnostics For Neurological Diseases
12/4/2024
ESYA Labs, a global leader in lysosomal biology and biomarker discovery for neurodegenerative diseases, has announced a transformative partnership with Alamar Biosciences, a pioneer in ultra-sensitive immunoassay technologies.
-
Function Health Collaborates With GRAIL To Offer Multi-Cancer Early Detection Test Nationwide
12/4/2024
Function Health, a revolutionary health management platform empowering people to live 100 healthy years, announces a collaboration with GRAIL, Inc., a healthcare company whose mission is to detect cancer early when it can be cured, to expand the reach of innovative cancer screening to transform cancer care.
-
LabVantage Solutions And The Netherlands Forensic Institute (NFI) Partner To Advance Digital Transformation In Forensic Science
12/4/2024
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS platforms enabling rapid deployment at reduced costs, and The Netherlands Forensic Institute (NFI) today jointly announced a partnership to digitalize forensic laboratory workflows as part of NFI’s IT renewal initiative.
-
Oncoinvent Announces Agreement With ARTBIO To Collaborate On Radiopharma Laboratory Facilities
12/4/2024
Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced that it has entered into an agreement with ARTBIO, a clinical-stage radiopharmaceutical company developing a new class of targeted alpha radioligand therapies.
-
Delve Bio Announces Launch Of Its Groundbreaking Genomic Infectious Disease Test, Delve Detect
12/4/2024
Delve Bio, a pioneer in metagenomic sequencing, today announced the commercial launch of Delve Detect, its groundbreaking metagenomic test for infectious diseases.
-
Beckman Coulter Life Sciences Accelerates Drug Discovery With Launch Of Cydem VT Automated Clone Screening System
12/3/2024
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, launches the Cydem VT Automated Clone Screening System, a revolutionary high-throughput microbioreactor platform for automated top clone screening.